OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
0.00
0.00%
0.0003 / 0.0005 (1 x 1)
Publish Date Publish Date | Title Title | Period End Date Period End Date | Status Status |
---|---|---|---|
05/12/2025 | Attorney Letter with Respect to Current Information - HRAL Attorney letter for Mar 31 2025 year end | 03/31/2025 | A |
05/06/2025 | Management Certification - HRAL Management certification | 03/31/2025 | A |
05/05/2025 | Management Certification - Mar 31 25 Management Certification | 03/31/2025 | A |
05/05/2025 | Annual Report - Mar 31 2025 Financial and OTC Guideline report | 03/31/2025 | A |
04/22/2025 | Management Certification - Mar 31 25 HRAL Management Certification | 03/31/2025 | A |
04/22/2025 | Annual Report - HRAL Financial Statements and OTC Guideline Report Mar 31 2025 | 03/31/2025 | A |
02/06/2025 | Quarterly Report - HRAL Quarterly Financial and OTC report | 12/31/2024 | A |
10/25/2024 | Quarterly Report - HearAtLast September 30 2024 quarterly report | 09/30/2024 | A |
08/23/2024 | Attorney Letter with Respect to Current Information - HRAL Attorney letter for Mar 31 2024 | 03/31/2024 | A |
08/02/2024 | Quarterly Report - HRAL June 30 2024 OTC Guideline and Financial Reports | 06/30/2024 | A |
No insider disclosure available for HRAL.
No SEC transactions available for HRAL.